InMed Pharmaceuticals Inc.
Member Profile
InMed is a leader in the manufacturing, development and commercialization of rare cannabinoids. Our manufacturing technologies produce several rare cannabinoids for pharmaceutical development and consumer products.
Sector
Biotechnology, Therapeutics
Biotechnology, Therapeutics
Area of Expertise
- Bioinformatics
- Bioprocessing
- Bioproducts
- Cannabinoids
- Drug Delivery
- Drug Discovery
- Ophthalmology
- Product Development
- Therapeutics
- Wellness solutions
Company Stage Phase 2 Clinical Studies
Employees outside Canada 7 employees
Stock Ticker INM - Nasdaq
Member Profile
Biotechnology, Therapeutics
InMed Pharmaceuticals Inc.
- Website www.inmedpharma.com
- Phone +1 (604) 669 7207
- Email info@inmedpharma.com
- Address
1445-885 West Georgia St.
Vancouver, BC
V6C 3E8 - Leadership Contact
Eric A. Adams, President & CEO
November 18, 2025
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901
July 28, 2025
InMed to Present INM-901 Data at Alzheimer’s Association International Conference (AAIC) 2025
No current content.